JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Pascalis, R.
Right arrow Articles by Lavitola, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Pascalis, R.
Right arrow Articles by Lavitola, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 1999, p. 430-432, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Performance Characteristics of an Enzyme-Linked Immunosorbent Assay for Determining Salivary Immunoglobulin G Response to Helicobacter pylori

R. De Pascalis,1,* M. Del Pezzo,1 G. Nardone,2 G. Budillon,2 and A. Lavitola1

Cattedra di Microbiologia Clinica, Dipartimento di Biologia e Patologia Cellulare e Molecolare,1 and Cattedra di Gastroenterologia, Dipartimento di Patologia Sistematica,2 Universita' degli Studi di Napoli "Federico II," 80131 Naples, Italy

Received 5 August 1998/Returned for modification 15 September 1998/Accepted 2 November 1998


    ABSTRACT
Top
Abstract
Text
References

We evaluated the salivary immunoglobulin G (IgG) immune response to Helicobacter pylori in 70 subjects by enzyme-linked immunosorbent assay (ELISA). Subjects with a positive H. pylori culture showed significantly higher titers of antibodies than subjects with no detectable H. pylori: the overall sensitivity and specificity of the test were 84 and 90%, respectively. The detection of salivary anti-H. pylori IgG antibodies may be considered as an alternative to serum IgG detection for ease of sample collection or when blood samples are not available in screening of patients with dyspepsia.


    TEXT
Top
Abstract
Text
References

An association between colonization of the gastric mucosa with Helicobacter pylori and peptic ulcer, chronic gastritis, and gastric carcinoma has been clearly established (5, 15, 16, 19, 20). The high prevalence of H. pylori, arguably the most common cause of chronic bacterial infection in humans (infecting 40 and 80% of individuals in developed and developing countries, respectively) (18, 19), demands the development of a noninvasive, sensitive, economic, and rapid technique of screening to detect infection. The current accepted diagnostic procedures for H. pylori infection include staining of histological samples, culturing of biopsy specimens, and the [13C]urea/[14C]urea breath test (2, 10, 11). The first two methods require invasive procedures and are therefore performed only for symptomatic subjects. The urea breath test, while not invasive, may be limited by its cost or the use of radiolabeled compounds (1). Although all strains of H. pylori cause some degree of persistent inflammation, the majority of people have no symptoms and a large number of infections may go undiagnosed (3, 4, 7, 17, 31, 33). Serological tests are available to evaluate total H. pylori-specific or H. pylori strain-specific antibodies (6, 12, 23, 26, 27, 32, 34), which could assist physicians in both diagnosis and follow-up of infected patients. Enzyme-linked immunosorbent assay (ELISA) is the most common commercial test whose performance is overall more accurate than that of latex agglutination or immunochromatography (27). Commercial Western blotting kits have recently been developed and are used to detect specific virulence markers (27, 28).

In this study, we investigated the salivary and serum anti-H. pylori immunoglobulin G (IgG) immune response in 50 dyspeptic patients and 20 healthy volunteers. As a preliminary definition of its clinical value, the performance of this assay was assessed against the histological, cultural, and biochemical detection of the bacterium. Multiple biopsy specimens, from the antrum and the body of the stomach, were obtained for histological, cultural, and biochemical examination. Five milliliters of venous blood and 5 ml of unstimulated saliva were obtained from all subjects. Specimens were stained with hematoxylin and eosin to evaluate the presence and severity of gastritis as well as with a modified Giemsa stain to identify H. pylori. Biopsy samples were cultured on pylori agar (bioMerieux) within 1 to 2 h of endoscopy. The plates were incubated for up to 6 days in 7 to 8% carbon dioxide. Isolates were considered to be H. pylori if they grew as 0.5- to 1-mm translucent greyish colonies, were gram-negative curved or s-shaped rods, and were positive for oxidase, catalase, and urease. The urease test (CP test; Yamanouchi Pharma) was carried out according to the manufacturer's instructions, and samples were examined for the presence of positive red color at 30 min and 24 h. Serum IgG against H. pylori antigens was detected by ELISA, using a commercially available kit (GAP test; Bio-Rad). Samples were considered positive when antibody titers were >20 U/ml, as per the manufacturer's guidelines. Evaluation of saliva IgG was performed by a modification of the above-described procedure. One hundred microliters of saliva was diluted 1:20 in phosphate-buffered saline supplemented with 1% (wt/vol) bovine serum albumin in duplicate wells. After a 1-h incubation at room temperature, a washing cycle with phosphate-buffered saline-0.05% Tween 20 was performed. One hundred microliters of peroxidase-conjugated anti-human IgG (supplied by the manufacturer) was added per well, and the plates were incubated for another hour at room temperature. A washing cycle was performed prior to the addition of 100 µl of freshly prepared substrate (H2O2) mixed with tetramethylbenzidine as a chromogen. The colorimetric reaction was then prolonged for 15 min at room temperature in the dark and terminated with the addition of 50 µl of 4 N H2SO4 per well. The adsorbance values (optical density [OD]) at 450 nm were recorded with an automated reader. Antibody titers of the H. pylori-positive and -negative subjects were compared by Student's t test; a P value of <0.05 indicated statistical significance. Sensitivity was defined as the ratio between true positives and true positives plus false negatives; specificity was defined as the ratio between true negatives and true negatives plus false positives. Accuracy was defined as the ratio between true positives plus true negatives and the total number of subjects. Positive predictive value (PPV) was defined as the ratio between true positives and true positives plus false positives and negative predictive value (NPV) was defined as the ratio between true negatives and true negatives plus false negatives.

Gastric ulcer, duodenal ulcer, or gastric erosions were diagnosed endoscopically in 33 of 70 (47%) subjects (in 30 of 50 patients with dyspepsia and in 3 of 20 asymptomatic healthy volunteers). H. pylori positivity was confirmed by culture for 31 subjects, by histology for 34 subjects, and by urease testing for 33 subjects. One asymptomatic healthy subject was H. pylori positive. The degrees of concordance were 91% for culture and the urease test, 87% for culture and histology, and 84% between histology and the urease test. The concordance for all tests was 81%. Serum antibodies against H. pylori were detected in 91% (30 of 33) of patients with gastric lesions and in 100% (31 of 31) with positive H. pylori identification. The performance of the anti-H. pylori saliva IgG assay for H. pylori-positive patients was compared with that for H. pylori-negative patients as defined by the microbiological detection of H. pylori (Fig. 1a). H. pylori-positive patients showed significantly higher titers of anti-H. pylori IgG (mean OD ± standard deviation, 0.500 ± 0.392) than H. pylori-negative subjects (OD, 0.134 ± 0.06) (P < 0.05). True-positive rates (sensitivity) and false-positive rates (100% minus specificity) were calculated at different cutoff values and plotted to obtain a receiver operating characteristic curve (Fig. 1b). In this analysis, the point that encloses the largest area, i.e., the point that lies farthest to the "northwest" of the graph (OD, 0.21), represents the best compromise between sensitivity and specificity (22) and was chosen for our initial analysis. At this cutoff rate, the salivary IgG test was considered positive for 30 of 70 (42%) patients (Table 1). The test was positive for 26 of 31 H. pylori-positive patients (sensitivity, 84%) and 4 of 39 H. pylori-negative patients (specificity, 90%). Accuracy was 87%; the PPV and NPV were 86 and 88%, respectively (Table 2). A sensitivity of 100% with a narrow 95% confidence interval (89 to 100%) was obtained by employing a cutoff OD of 0.12 (31 of 31 positive tests for H. pylori-positive patients) (Fig. 1). The performance of the saliva test at this cutoff rate was identical to that of the serum IgG test (Table 1).


View larger version (13K):
[in this window]
[in a new window]
  		FIG. 1.   ELISA detection of salivary anti-H. pylori IgG. (a) Distribution of salivary IgG responses for H. pylori (Hp)-positive and -negative patients. (b) Receiver operating characteristic curve for the salivary IgG response. (Inset) Calculated assay sensitivity and specificity at different cutoff levels.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Results of culture, IgG, urease tests, and histology


                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Performance of IgG and urease tests and histology compared with culturea

It is widely accepted that the serum anti-H. pylori IgG test is reliable for detecting H. pylori (12, 23, 27, 32). The diagnostic value and limitations of the GAP test ELISA have been addressed in several studies (8, 26, 27, 29). H. pylori antibodies can also be measured in salivary secretions, but the value of this procedure has not been established (9, 13, 14, 21, 24). In this study we have evaluated the performance of a test for the detection of salivary IgG against H. pylori and calculated its sensitivity and specificity at different cutoff values. The choice of cutoff line is an important parameter, as it affects the assay's specificity and sensitivity in a reciprocal manner, with a major impact on the clinical decision-making process. A positive result at a cutoff level allowing for a high specificity (OD of 0.38 in our study) for a patient with ulcer and/or a positive urease test may justify the starting of therapy while awaiting the results of cultural and/or histological examination. When employed for population screening, on the other hand, a test requires a high sensitivity and, therefore, a lower cutoff. Its attendant low specificity may be an acceptable trade-off for certain clinical purposes. The high NPV at the cutoff of 0.12 could be of assistance in excluding patients from further invasive diagnostic procedures.

The sensitivity and specificity of a test depend upon certain characteristics of the population examined. Confounding factors, such as antibiotic therapy, may impact the performance of anti-H. pylori IgG assays. Five patients receiving anti-H. pylori therapy in the months prior to the study had positive salivary IgG tests but negative culture, histology, and urease results. This finding is consistent with the results of long-term serological surveillance studies (30) that showed that IgG antibody values were lower, but not yet within the normal range, 6 to 12 months after anti-H. pylori therapy. The possibility of "patchy" infections could also contribute to the low specificity of immunological tests compared to those of cultural or histological tests.

These results show that ELISA for detection of salivary anti-H. pylori IgG is a rapid, noninvasive, inexpensive test that may be considered as an alternative to the serum IgG test when blood samples are not available or in pediatric populations. While endoscopy and tissue biopsies remain irreplaceable for the definitive confirmation of the H. pylori status, the present study supports a role for the salivary IgG antibody response in screening patients with dyspepsia. Although certain ulcers and gastritis occur independently of H. pylori infection, a negative anti-H. pylori salivary IgG status may help in reducing the number of unnecessary endoscopies, especially in low-risk patients, such as subjects under 45 years of age (25).


    ACKNOWLEDGMENTS

We thank E. Bonvini (Laboratory of Immunobiology, DMA, OTRR, CBER) for helpful discussions and for critical review of the manuscript and S. Misra (OTRR, CBER) for assistance with the statistical analysis.


    FOOTNOTES

* Corresponding author. Present address: Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm. 5B38, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 496-0419. Fax: (301) 402-0711 or (301) 480-2002. E-mail: pascalir{at}mail.nih.gov.


    REFERENCES
Top
Abstract
Text
References

1. Atherton, J. C. 1997. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 11(Suppl. 1):11-20.
2. Barthel, J. S., and E. D. Everett. 1990. Diagnosis of Campylobacter pylori infections: the "gold standard" and the alternatives. Rev. Infect. Dis. 12:S107-S114.
3. Blaser, M. J., P. H. Chyou, and A. Nomura. 1995. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res. 55:562-565[Abstract/Free Full Text].
4. Blaser, M. J. 1992. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727[Medline].
5. Cover, T. L., and M. J. Blaser. 1995. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease and gastric cancer. Science 1:21-26.
6. Crabtree, J. E., J. I. Wyatt, G. M. Sobala, G. Miller, D. S. Tompkins, J. N. Primrose, and A. G. Morgan. 1993. Systemic and mucosal humoral response to Helicobacter pylori in gastric cancer. Gut 34:1339-1343[Abstract/Free Full Text].
7. Crabtree, J. E., and S. M. Farmery. 1995. Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent. Lab. Investig. 73:742-745[Medline].
8. Crabtree, J. E., T. M. Shallcross, R. V. Heatley, and J. I. Wyatt. 1991. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J. Clin. Pathol. 44:326-328[Abstract/Free Full Text].
9. Fallone, C. A., M. Elizov, O. Cleland, J. A. Thompson, G. E. Wild, J. Lough, J. Faria, and A. N. Barkun. 1996. Detection of Helicobacter pylori infection by saliva IgG testing. Am. J. Gastroenterol. 91:1145-1149[Medline].
10. Graham, D. Y., P. D. Klein, D. J. Evans, L. C. Alpert, A. R. Operkun, and T. W. Boutton. 1987. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet i:1174-1179.
11. Jones, D. M., A. M. Lessels, and J. Eldrig. 1984. Campylobacter-like organisms in the gastric mucosa: culture, histological and serological studies. J. Clin. Pathol. 37:1002-1006[Abstract/Free Full Text].
12. Kosunen, T. U., K. Seppala, S. Sarna, and P. Sipponen. 1992. Diagnostic value of decreasing IgG, IgA and IgM antibody titers after eradication of Helicobacter pylori. Lancet 339:893-895[Medline].
13. Luzza, F., M. Maletta, M. Imeneo, A. Marcheggiano, C. Iannoni, L. Biancone, and F. Pallone. 1995. Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Am. J. Gastroenterol. 90:1820-1823[Medline].
14. Luzza, F., M. Maletta, M. Imeneo, P. Doldo, R. Marasco, L. Biancone, and F. Pallone. 1995. Salivary specific IgG is a sensitive indicator of the humoral immune response to Helicobacter pylori. FEMS Immunol. Med. Microbiol. 10:281-284[Medline].
15. Marshall, B., and J. R. Warren. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275.
16. Marshall, B., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1314.
17. Marvaso, A., and S. Esposito. 1995. Ruolo patogenetico dell'Helicobacter pylori nelle malattie gastroduodenali. Infezioni Med. 4:173-188.
18. Megraud, F. 1995. Epidemiology of Helicobacter pylori infection: where are we in 1995? Eur. J. Gastroenterol. Hepatol. 7:292-295[Medline].
19. NIH Consensus Development Conference. 1994. Helicobacter pylori in peptic ulcer disease. National Institutes of Health, Bethesda, Md.
20. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of carcinoma. N. Engl. J. Med. 325:1127-1131[Abstract].
21. Reilly, T. G., V. Poxon, D. S. Sanders, T. S. Elliott, and R. P. Walt. 1997. Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests. Gut 40:454-458[Abstract/Free Full Text].
22. Sackett, D. L., R. B. Haynes, and P. Tugwell. 1985. Clinical epidemiology: a basic science for clinical medicine. Little, Brown & Co., Boston, Mass.
23. Schembri, M. A., S. K. Lin, and J. R. Lambert. 1993. Comparison of commercial tests for Helicobacter pylori antibodies. J. Clin. Microbiol. 31:2621-2624[Abstract/Free Full Text].
24. Simor, A. E., E. Lin, F. Saibil, L. Cohen, M. Louie, S. Pearen, and H. A. Donhoffer. 1996. Evaluation of enzyme immunoassay for detection of salivary antibody to Helicobacter pylori. J. Clin. Microbiol. 34:550-553[Abstract].
25. Sobala, G. M., J. E. Crabtree, J. A. Pentith, B. J. Rathbone, T. M. Shallcross, J. I. Wyatt, M. F. Dixon, R. V. Heatlet, and A. T. R. Axon. 1991. Screening dyspepsia by serology to Helicobacter pylori. Lancet 338:94-96[Medline].
26. Taha, A. S., J. Reid, P. Boothman, C. G. Gemmell, F. D. Lee, R. D. Sturrock, and R. I. Russell. 1993. Serological diagnosis of Helicobacter pylori: evaluation of four tests in the presence and absence of non-steroidal anti-inflammatory drugs. Gut 34:461-465[Abstract/Free Full Text].
27. Vaira, D., J. Holton, M. Menegatti, F. Landi, C. Ricci, A. Ali', L. Gatta, S. Farinelli, C. Acciardi, B. Massardi, M. Miglioli, and the Italian Helicobacter pylori Study Group. 1998. Blood tests in the management of Helicobacter pylori infection. Gut 43(Suppl. 1):S39-S46.
28. Vaira, D., M. Menegatti, M. Fusconi, S. Farinelli, F. Landi, N. Figura, S. Quan, G. Monti, J. Holton, C. Ricci, A. Ali', F. Mucci, C. Acciardi, G. Lupinacci, F. Milesi, W. Giorcelli, P. Maiolo, A. Zambelli, A. Petronelli, F. Pannuti, R. Corinaldesi, and M. Miglioli. 1997. Helicobacter pylori: detection of anti-lysate, -CagA and -VacA reactivity by recombinant immunoblot assay in sera from 2924 subjects. Gut 41:A163.
29. van den Oever, H. L. A., R. J. L. F. Loffeld, and E. E. Stobberingh. 1991. Usefulness of a new serological test (Bio-Rad) to diagnose Helicobacter pylori-associated gastritis. J. Clin. Microbiol. 29:283-286[Abstract/Free Full Text].
30. Veenedaal, R. A., A. S. Pena, J. L. Meijer, H. P. N. Endtz, M. M. C. van der Est, W. van Duijn, F. Eulerink, J. Kreuning, and C. B. H. W. Lamars. 1991. Long term surveillance after treatment of Helicobacter pylori infection. Gut 32:1291-1294[Abstract/Free Full Text].
31. Wyatt, J. I., and M. S. Dixon. 1988. Chronic gastritis---a pathogenetic approach. J. Pathol. 154:113-124[Medline].
32. Wyatt, J. I., and B. J. Rathbone. 1989. The role of serology in the diagnosis of Helicobacter pylori infection. Scand. J. Gastroenterol. 24:S27-S34.
33. Xiang, Z., S. Censini, P. F. Bayeli, J. L. Telford, N. Figura, R. Rappuoli, and A. Covacci. 1995. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63:94-98[Abstract].
34. Xiang, Z., M. Bugnoli, A. Ponzetto, A. Morgando, N. Figura, A. Covacci, R. Petracca, C. Pennatini, S. Censini, D. Armellini, and R. Rappuoli. 1993. Detection in an immunoassay of an immunoresponse to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 12:739-745[Medline].

Journal of Clinical Microbiology, February 1999, p. 430-432, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Pascalis, R.
Right arrow Articles by Lavitola, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Pascalis, R.
Right arrow Articles by Lavitola, A.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS